J&J Recalls Baby Powder on Asbestos Concern -- Update
18 Octobre 2019 - 08:14PM
Dow Jones News
By Peter Loftus
Johnson & Johnson said it recalled one lot, about 33,000
bottles, of its Johnson's Baby Powder because the U.S. Food and
Drug Administration found a small amount of asbestos in a single
bottle, a discovery likely to fuel existing concerns about the
safety of the famous product.
The health-products company, which is well known among consumers
for its namesake powder, said Friday it is recalling the bottles
out of an abundance of caution despite the low levels of asbestos
reported. The recall was triggered by FDA testing.
The recall comes at a vulnerable time for J&J, which has
been fighting tens of thousands of lawsuits over its talcum powder,
opioid drugs and other products. The stock fell 5% in midday
trading on the New York Stock Exchange.
Admission of an asbestos taint could complicate J&J's
defense against talcum-powder lawsuits in particular, since the
company has been arguing that it hasn't detected asbestos in
decades of testing.
The recall "is a negative for JNJ's reputation and potentially
strengthens the plaintiffs' argument in the ongoing talc lawsuits,"
Wells Fargo analysts said in a research note Friday.
J&J faces lawsuits from about 15,500 people in the U.S.
claiming that use of J&J's baby powder and its other
talc-containing products caused ovarian cancer and a rare cancer
known as mesothelioma. Some of the lawsuits allege that asbestos in
the talc products contributed to the cancer because asbestos is a
known carcinogen.
J&J says numerous tests over the past 40 years showed no
asbestos in its baby powder, that its talc products are safe and
don't cause cancer. J&J has won some cases at trial but has
lost some costly verdicts in other talc trials.
Plaintiffs' lawyers say asbestos was present in J&J's talcum
powder in greater concentrations many decades ago, and that the
concentrations dissipated as J&J found other mines. But the
lawyers say more recent tests by experts they have hired still have
also shown trace amounts in products made since the 1970s. J&J
has disputed the validity of those tests.
Ted Meadows, an attorney with Beasley Allen in Alabama who has
represented plaintiffs in several talcum-powder trials, said the
recall will strengthen his arguments at future trials.
"It's just confirmation of what we've been saying all along," he
said. "It's contra to what J&J has been telling the public and
telling juries across the country."
The New Brunswick, N.J., company said it has a "rigorous testing
standard in place to ensure its cosmetic talc is safe and years of
testing, including the FDA's own testing on prior occasions -- and
as recently as last month -- found no asbestos."
J&J said Friday the latest FDA test indicated the presence
of chrysotile asbestos contamination in well under 1% of the sample
from a single bottle. J&J said the bottle was purchased from an
online retailer, but didn't identify the retailer. It said the lot
was produced and shipped in the U.S. last year.
An FDA spokeswoman declined to comment immediately.
J&J is investigating the matter, and at this early stage it
can't confirm whether the sample was taken from a bottle with an
intact seal, or whether the product tested was authentic or
counterfeit.
Colin Kellaher contributed to this article.
Write to Peter Loftus at peter.loftus@wsj.com
(END) Dow Jones Newswires
October 18, 2019 13:59 ET (17:59 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024